期刊文献+

血液透析患者合并心力衰竭原因分析及临床护理干预效果观察 被引量:2

Reason discussion and clinical nursing intervention effect observation of hemodialysis patient complicated with heart failure
下载PDF
导出
摘要 目的分析血液透析患者合并心力衰竭的原因及临床护理干预效果。方法回顾性分析815例血液透析患者的临床资料,统计合并心力衰竭的患者比例并总结其发生原因。将血液透析合并心力衰竭患者分为2组,观察组40例加强护理干预,对照组39例采用常规护理,比较分析2组的临床效果。结果血液透析患者合并心力衰竭的发生率为9.7%;经过护理,观察组临床总有效率略高于对照组,差异无统计学意义(P>0.05);观察组生活质量评分为(49.5±4.0)分优于对照组的(42.0±3.2)分,差异有统计学意义(P<0.05)。结论临床工作者应掌握血液透析患者合并心力衰竭的原因,并针对性地采取临床护理措施,以提高患者的生活质量。 Objective To investigate the reason and clinical nursing intervention effect of hemodialysis patient complicated with heart failure.Methods Retrospectively analyzed the clinical data of 815 cases patients with hemodialysis,calculated out the proportion of patient with heart failure and summarized the reason for its occurrence.The hemodialysis patients complicated with heart failure were divided into two groups,observation group(40 cases) enhanced nursing intervention,control group(39 cases) were given conventional care.Compared the clinical effect of two groups.Results The incidence rate of hemodialysis patients complicated with heart failure was 9.7%;After nursing,the clinical total efficiency of observation group was higher than that of control group,there was no significant difference(P〉0.05);The quality of life score of observation group[(49.5±4.0)scores] was better than that of control group[(42.0±3.2)scores],the difference was statistically significant(P〈0.05).Conclusion Clinicians should grasp the reason of hemodialysis patients complicated with heart failure and take targeted measures of clinical care to improve the quality of life of patients.
作者 文鸿 曾兴蓉
出处 《临床合理用药杂志》 2011年第19期43-44,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 心力衰竭 血液透析 护理干预 Heart failure Hemodialysis Nursing intervention
  • 相关文献

参考文献10

二级参考文献24

  • 1马骏,郝传明,林善锬.双(三)腔留置导管在长期血透中的应用[J].中华肾脏病杂志,1995,11(2):66-68. 被引量:22
  • 2郎学聪,张亮,刘丽,贾钰铭,刘牧,胡萍.血液透析对尿毒症并发急性心力衰竭的治疗作用[J].现代预防医学,2007,34(15):2973-2974. 被引量:3
  • 3Kalon KL,Joan LP, William BK. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22 (Suppl A):6A-13A.
  • 4Hung YT, Cheug NT, Ip S. Epidemiology of heart failure in Hong Kong,1997. Hong Kong Med J, 2000,6:159-162.
  • 5Packer M, Coats AJS, Fowler MB, et al. For the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effects of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651-1658.
  • 6Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J, 2001, 22: 1527-1561.
  • 7Hunt HA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the international society for heart and lung transplantation. Circulation, 2001, 104:2996-3007.
  • 8方积乾,统计与预测,1998年,增刊,40页
  • 9柯惠新,调查研究中的统计分析法,1992年
  • 10叶任高.内科学[M] 5版[M].北京:人民卫生出版社,2001.22-31.

共引文献1159

同被引文献17

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部